AFFY Management from Arlene Morris to current day one always seems to be crooks!
Just wondering whether they played a sucker game and trapped all the shorts?
Omantys and other ESA's are always carry lots of risk, nothing is big, since they treat a population which is always fragile ones already faced mutitude of complexities.
When they recalled the drug, they should have recalled for enrolling new patients and should not have recalled for those who are under Omanty's treatment. Why pull a drug when it was safe for the 24000+ population and who are being treated for months? FDA will come back and force AFFY & Takeda to provide the drug for those already under Omanty's treatment with no stated reactions. THe pressure from drug administrators as well as the Patient population will be huge for FDA / AFFY/ Takeda to ignore.
Having known this company for almost 2/3 years they are there to serve themselves.